Effect of the sphingosine kinase 1 selective inhibitor, PF-543 on arterial and cardiac remodelling in a hypoxic model of pulmonary arterial hypertension
Neil MacRitchie(University of Strathclyde), Nigel J. Pyne(University of Strathclyde)
Cited by 43
Related Papers
Sphingosine 1-phosphate and cancer
|Nature reviews. Cancer|2010|830
Sphingosine 1-phosphate signalling in mammalian cells
|Biochemical Journal|2000|695
Sphingosine Kinases: Emerging Structure–Function Insights
|Trends in Biochemical Sciences|2016|73
Recent advances in the role of sphingosine 1‐phosphate in cancer
|FEBS Letters|2020|69
Sphingosine Kinase 2 in Autoimmune/Inflammatory Disease and the Development of Sphingosine Kinase 2 Inhibitors
|Trends in Pharmacological Sciences|2017|42